The risk of recurrence is highest in the first six months after angioplasty, with rates as high as 35% reported in some studies.
Some patients, such as those with IIb or stage III melanoma, are at high risk for the development of recurrence after treatment.
There is a high risk of tumor recurrence and metastases after transplantation.
Treating the patient who has no evidence of residual disease but who is at high risk for recurrence
The risk of stroke recurrence can be reduced by managing risk factors such as high blood pressure, high cholesterol, diabetes, and atrial fibrillation. Taking prescribed medications, making lifestyle changes such as eating a healthy diet, exercising regularly, and not smoking can also help reduce the risk of stroke recurrence. Regular follow-up with healthcare providers for monitoring and adjusting treatment as needed is essential.
Male infants with a family history of pyloric stenosis are more at risk of having the condition, which tends to occur less often in females, blacks, and Asians.
Patients at highest risk for a recurrence of bleeding are those with portal hypertension.
There is a danger of puncturing the vessel with the guidewire during an angioplasty, although the risk is very small. Patients must be monitored for hematoma or hemorrhage at the puncture site
The risk for tumor recurrence is thought to be unaffected by whether the patient undergoes a total pancreatectomy or a pancreaticoduodenectomy.
An additional risk specific to cancer patients is recurrence of the cancer.
Risks associated with mitral valve stenosis depend on pre-existing risk factors. It is of utmost concern whether one is at risk of death or of brain damage.
risks are greater with obese patients or those who have had multiple earlier operations or the prior placement of mesh patches. The risk of complications has been shown to be about 13%. The risk of recurrence and repeat surgery is as high as 52%
risk for impaired physical mobility related to neuromuscular impairment (Medsurg)